Meeting notes from the 3rd IAS Conference. Advances in the treatment of hepatitis/HIV coinfection.
New studies address the optimal duration of HCV treatment, early predictors of treatment response, and risk factors for liver-related mortality.
Sax
Paul E
PE
D001938:Brazil; D002985:Clinical Protocols; D003226:Congresses as Topic; D015658:HIV Infections / Q000150:complications / Q000188:drug therapy*; D006505:Hepatitis / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D012307:Risk Factors